Acuitas Investments, LLC - HARVARD BIOSCIENCE INC ownership

HARVARD BIOSCIENCE INC's ticker is HBIO and the CUSIP is 416906105. A total of 99 filers reported holding HARVARD BIOSCIENCE INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Acuitas Investments, LLC ownership history of HARVARD BIOSCIENCE INC
ValueSharesWeighting
Q3 2023$1,039,658
+5.0%
241,781
+34.1%
0.61%
+5.9%
Q2 2023$989,847
-67.5%
180,300
-58.3%
0.58%
-55.5%
Q4 2021$3,049,000
+16.2%
432,445
+15.1%
1.30%
+13.4%
Q3 2021$2,623,000
-3.6%
375,836
+15.1%
1.14%
-15.7%
Q2 2021$2,720,000
+149.1%
326,491
+63.2%
1.36%
+117.1%
Q1 2021$1,092,000200,0000.63%
Other shareholders
HARVARD BIOSCIENCE INC shareholders Q1 2022
NameSharesValueWeighting ↓
AMH Equity Ltd 2,053,907$8,626,4099.88%
B. Riley Asset Management, LLC 3,408,796$14,316,9435.93%
Meros Investment Management, LP 1,124,206$4,721,6652.69%
Harvey Partners, LLC 2,712,700$11,393,3401.41%
Archon Capital Management LLC 1,361,769$5,719,4301.28%
PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. 2,947,329$12,378,7820.80%
BARD ASSOCIATES INC 291,297$1,223,4480.50%
Portolan Capital Management 1,043,546$4,382,8930.42%
HEARTLAND ADVISORS INC 1,200,000$5,040,0000.31%
EAM Investors, LLC 345,546$1,451,2930.28%
View complete list of HARVARD BIOSCIENCE INC shareholders